On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The new online Learning Center with new content can still be found under the “Training” folder on ...